Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
MariTide (maridebart cafraglutide) Dual action: GLP-1 (glucagon-like peptide-1) receptor agonist (stimulates GLP-1 pathway, reducing appetite and food intake) plus GIP (glucose-dependent insulinotropic polypeptide) receptor antagonist (blocks GIP, a hormone involved in insulin and fat regulation)
Since Wegovy commonly causes symptoms such as nausea, diarrhoea, constipation, and abdominal discomfortsymptoms that overlap significantly with IBSthere is potential for these effects to exacerbate existing bowel symptoms or make it difficult to distinguish between IBS flares and medication side effects
They may contain high-risk ingredients, such as prescription or controlled drugs, and additives or contaminants that may or may not be listed on the label
Coverage varies by insurance provider and plan
Who should consider each compound The right choice depends on individual circumstances, goals, risk tolerance, and practical constraints
